| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Department of Biochemistry and Molecular Biology,
2 Eppley Institute for Research in Cancer and Allied Diseases, and
3 Department of Preventive and Societal Medicine, Biostatistics Section, University of Nebraska Medical Center, Omaha, Nebraska
The MUC4 mucin is a high molecular weight membrane-bound glycoprotein. It is aberrantly expressed in pancreatic tumors and tumor cell lines with no detectable expression in the normal pancreas. A progressive increase of MUC4 expression has also been observed in pancreatic intraepithelial neoplasia, suggesting its association with disease development. Here, we investigated the consequences of silencing MUC4 expression in an aggressive and highly metastatic pancreatic tumor cell line CD18/HPAF that expresses high levels of MUC4. The expression of MUC4 was down-regulated by the stable integration of a plasmid-construct expressing antisense-MUC4 RNA. A decrease in MUC4 expression, confirmed by Western blot and immunofluorescence analyses, resulted in diminished growth and clonogenic ability of antisense-MUC4-transfected (EIAS19) cells compared with parental, empty vector (ZEO) and sense transfected (ES6) control cells. In addition, EIAS19 cells displayed a significant decrease in tumor growth and metastatic properties when transplanted orthotopically into the immunodeficient mice. In vitro biological assays for motility, adhesion, and aggregation demonstrated a 3-fold decrease in motility of EIAS19 cells compared with control cells, whereas these cells adhered more and showed an increase in cellular aggregation. Interestingly, MUC4 down-regulation also correlated with the reduced expression of its putative interacting partner, HER2/neu, in antisense-MUC4-transfected cells. In conclusion, the present work demonstrates, for the first time, a direct association of the MUC4 mucin with the metastatic pancreatic cancer phenotype and provides experimental evidence for a functional role of MUC4 in altered growth and behavioral properties of the tumor cell.
This article has been cited by other articles:
|
|
 |
|
  N. RABIAU, P. DECHELOTTE, L. GUY, S. SATIH, R. BOSVIEL, L. FONTANA, J.-L. KEMENY, J.-P. BOITEUX, Y.-J. BIGNON, and D. BERNARD-GALLON Immunohistochemical Staining of Mucin 1 in Prostate Tissues In Vivo, March 1, 2009; 23(2): 203 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Chauhan, K. Vannatta, M. C. Ebeling, N. Vinayek, A. Watanabe, K. K. Pandey, M. C. Bell, M. D. Koch, H. Aburatani, Y. Lio, et al. Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer Cancer Res., February 1, 2009; 69(3): 765 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bafna, A. P. Singh, N. Moniaux, J. D. Eudy, J. L. Meza, and S. K. Batra MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells Cancer Res., November 15, 2008; 68(22): 9231 - 9238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Blalock, S. J. Spurr-Michaud, A. S. Tisdale, and I. K. Gipson Release of Membrane-Associated Mucins from Ocular Surface Epithelia Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1864 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chaturvedi, A. P. Singh, S. Chakraborty, S. C. Chauhan, S. Bafna, J. L. Meza, P. K. Singh, M. A. Hollingsworth, P. P. Mehta, and S. K. Batra MUC4 Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells Cancer Res., April 1, 2008; 68(7): 2065 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chaturvedi, A. P. Singh, and S. K. Batra Structure, evolution, and biology of the MUC4 mucin FASEB J, April 1, 2008; 22(4): 966 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fauquette, S. Aubert, S. Groux-Degroote, B. Hemon, N. Porchet, I. Van Seuningen, and P. Pigny Transcription factor AP-2{alpha} represses both the mucin MUC4 expression and pancreatic cancer cell proliferation Carcinogenesis, November 1, 2007; 28(11): 2305 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Blalock, S. J. Spurr-Michaud, A. S. Tisdale, S. R. Heimer, M. S. Gilmore, V. Ramesh, and I. K. Gipson Functions of MUC16 in Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4509 - 4518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-K. Shyu, M.-C. Lin, J.-C. Shih, C.-N. Lee, J. Huang, C.-H. Liao, I-F. Huang, H.-Y. Chen, M.-C. Huang, and F.-J. Hsieh Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro Hum. Reprod., October 1, 2007; 22(10): 2723 - 2732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chaturvedi, A. P. Singh, N. Moniaux, S. Senapati, S. Chakraborty, J. L. Meza, and S. K. Batra MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins Mol. Cancer Res., April 1, 2007; 5(4): 309 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Singh, P. Chaturvedi, and S. K. Batra Emerging Roles of MUC4 in Cancer: A Novel Target for Diagnosis and Therapy Cancer Res., January 15, 2007; 67(2): 433 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Moniaux, W. M. Junker, A. P. Singh, A. M. Jones, and S. K. Batra Characterization of Human Mucin MUC17: COMPLETE CODING SEQUENCE AND ORGANIZATION J. Biol. Chem., August 18, 2006; 281(33): 23676 - 23685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Funes, J. K. Miller, C. Lai, K. L. Carraway III, and C. Sweeney The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3 J. Biol. Chem., July 14, 2006; 281(28): 19310 - 19319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Ramsauer, V. Pino, A. Farooq, C. A. Carothers Carraway, P. J.I. Salas, and K. L. Carraway Muc4-ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2 Mol. Biol. Cell, July 1, 2006; 17(7): 2931 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lievin-Le Moal and A. L. Servin The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota Clin. Microbiol. Rev., April 1, 2006; 19(2): 315 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Saitou, M Goto, M Horinouchi, S Tamada, K Nagata, T Hamada, M Osako, S Takao, S K Batra, T Aikou, et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas J. Clin. Pathol., August 1, 2005; 58(8): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Guha, G. Eibl, K. Kisfalvi, R. S. Fan, M. Burdick, H. Reber, O. J. Hines, R. Strieter, and E. Rozengurt Broad-Spectrum G Protein-Coupled Receptor Antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: A Dual Inhibitor of Growth and Angiogenesis in Pancreatic Cancer Cancer Res., April 1, 2005; 65(7): 2738 - 2745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nagy, E. Friedlander, M. Tanner, A. I. Kapanen, K. L. Carraway, J. Isola, and T. M. Jovin Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line Cancer Res., January 15, 2005; 65(2): 473 - 482. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
